Collects royalties on women’s health medicines and licenses their commercialization to pharmaceutical companies.
10-K for FY2025, filed Mar 30, 2026TherapeuticsMD is a pharmaceutical royalty company that owns or has rights to trademarks, service marks, or trade names that were…View ↗
TherapeuticsMD was previously a women’s healthcare company with a mission of creating and commercializing innovative products to support…View ↗
The Company also has license agreements with strategic partners to commercialize IMVEXXY and BIJUVA outside of the U.S.View ↗
Portfolio of our royalty-bearing productsView ↗
Pharmaceutical companies license the products to commercialize them in their territories; the company currently collects license revenue from three licensees.
10-K for FY2025, filed Mar 30, 2026TherapeuticsMD was previously a women’s healthcare company with a mission of creating and commercializing innovative products to support…View ↗
The Company also has license agreements with strategic partners to commercialize IMVEXXY and BIJUVA outside of the U.S.View ↗
Sales concentrationView ↗
Our business model is dependent on third parties achieving specified milestones and product sales. For information on the concentration of…View ↗
8-K, filed Aug 11, 2026
The Company continues to evaluate a variety of strategic alternatives that may include, but are not limited to, an acquisition, merger…View ↗
Loading...